DRUG · Unmapped registry intervention
Ceralasertib
Find medicine records ·
Find other trials using this name
Clinical trial
Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors
NCT03682289
Drugs and interventions used in this trial
3 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Mapped RxNorm record
Olaparib
Normalized identity: olaparibView linked drug · Find medicine records ·
Find other trials using this name
DRUG · Mapped RxNorm record
Durvalumab
Normalized identity: durvalumabView linked drug · Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedCeralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors
Design: INTERVENTIONAL · Status: ACTIVE NOT RECRUITING · Phase: PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Locally Advanced Pancreatic Cancerunresolved
Metastatic Malignant Solid Neoplasmunresolved
Metastatic Renal Cell Carcinomaunresolved
Metastatic Urothelial Carcinomaunresolved
Metastatic Pancreatic Cancerunresolved
Stage III Pancreatic Cancerunresolved
Stage III Renal Cell Cancerunresolved
Stage IV Pancreatic Cancerunresolved
Stage IV Renal Cell Cancerunresolved
Endometrial Cancerverified · MONDO: endometrial cancer
Interventions
CeralasertibDRUG
OlaparibDRUG · verified · RxNorm: olaparib
DurvalumabDRUG · verified · RxNorm: durvalumab
Sponsors & collaborators
Rahul Aggarwallead sponsor
AstraZenecacollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03682289 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.